美股财报 | Wave Life Sciences发布Q2财报前半年累计净亏损同比扩大50.97%

同花顺iNews07-31

wave life sciences(WVE)发布Q2财报，2025财年前六月累计收入1787.40万美元，去年同期累计收入为3223.00万美元，同比减少44.54%。2025财年前六月累计净亏损9734.70万美元，去年同期累计净亏损为6448.10万美元，同比扩大50.97%。本财年累计基本每股收益为-0.6美元，去年同期为-0.5美元。公司所属行业为制药。【公司信息】wave life ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555081074?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-31 10:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2555081074","market":"us","top_or_hot":-1,"title":"美股财报 | Wave Life Sciences发布Q2财报 前半年累计净亏损同比扩大50.97%","media":"同花顺iNews","content":"<div>\n<p>wave life sciences(WVE)发布Q2财报，2025财年前六月累计收入1787.40万美元，去年同期累计收入为3223.00万美元，同比减少44.54%。2025财年前六月累计净亏损9734.70万美元，去年同期累计净亏损为6448.10万美元，同比扩大50.97%。本财年累计基本每股收益为-0.6美元，去年同期为-0.5美元。公司所属行业为制药。【公司信息】wave life ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731101557a46c8303&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股财报 | Wave Life Sciences发布Q2财报 前半年累计净亏损同比扩大50.97%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股财报 | Wave Life Sciences发布Q2财报 前半年累计净亏损同比扩大50.97%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-31 10:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731101557a46c8303&s=b><strong>同花顺iNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>wave life sciences(WVE)发布Q2财报，2025财年前六月累计收入1787.40万美元，去年同期累计收入为3223.00万美元，同比减少44.54%。2025财年前六月累计净亏损9734.70万美元，去年同期累计净亏损为6448.10万美元，同比扩大50.97%。本财年累计基本每股收益为-0.6美元，去年同期为-0.5美元。公司所属行业为制药。【公司信息】wave life ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731101557a46c8303&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WVE","symbol_name":"Wave Life Sciences Pte. Ltd","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731101557a46c8303&s=b","article_id":"2555081074","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731101557a46c8303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555081074","pubTimestamp":1753927203,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"wave life sciences发布Q2财报，2025财年前六月累计收入1787.40万美元，去年同期累计收入为3223.00万美元，同比减少44.54%。wave life sciences Ltd.于2012年7月23日在新加坡注册成立。该公司是一家临床阶段的生物技术公司，专注于释放RNA药物或靶向核糖核酸的广泛潜力，以改变人类健康。该公司的RNA药物平台PRISMTM结合了多种模式、化学创新和对人类遗传学的深刻见解，以提供治疗罕见和流行疾病的科学突破。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"WVE":"Wave Life Sciences Pte. Ltd"},"translate_title":"U.S. Stock Financial Report | Wave Life Sciences releases Q2 financial report, the cumulative net loss in the first half of the year expanded by 50.97% year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WVE":0.9},"content_text":"wave life sciences(WVE)发布Q2财报，2025财年前六月累计收入1787.40万美元，去年同期累计收入为3223.00万美元，同比减少44.54%。2025财年前六月累计净亏损9734.70万美元，去年同期累计净亏损为6448.10万美元，同比扩大50.97%。本财年累计基本每股收益为-0.6美元，去年同期为-0.5美元。公司所属行业为制药。【公司信息】wave life sciences Ltd.于2012年7月23日在新加坡注册成立。 该公司是一家临床阶段的生物技术公司，专注于释放RNA药物（也称为寡核苷酸）或靶向核糖核酸（“RNA”）的广泛潜力，以改变人类健康。该公司的RNA药物平台PRISMTM结合了多种模式、化学创新和对人类遗传学的深刻见解，以提供治疗罕见和流行疾病的科学突破。公司的RNA靶向模式工具包包括RNA编辑、剪接、反义沉默和RNA干扰（“RNAi”），为公司设计和可持续交付最佳解决疾病生物学的候选药物提供了独特的能力。该公司主导的项目涉及罕见和流行的疾病，包括α-1抗胰蛋白酶缺乏症（“AATD”）、肥胖症、杜氏肌营养不良症（“DMD”）和亨廷顿氏病（“HD”）。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555081074","isCrawlerRequest":true}

美股财报 | Wave Life Sciences发布Q2财报 前半年累计净亏损同比扩大50.97%

精彩评论

美股财报 | Wave Life Sciences发布Q2财报前半年累计净亏损同比扩大50.97%